174 related articles for article (PubMed ID: 249793)
1. Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin.
Faville RJ; Zaske DE; Kaplan EL; Crossley K; Sabath LD; Quie PG
JAMA; 1978 Oct; 240(18):1963-5. PubMed ID: 249793
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations.
Bayer AS; Lam K
J Infect Dis; 1985 Jan; 151(1):157-65. PubMed ID: 3965588
[TBL] [Abstract][Full Text] [Related]
3. Staphylococcus aureus infection of dialysis shunt: absence of synergy with vancomycin and rifampin.
Tofte RW; Solliday J; Rotschafer J; Crossley KB
South Med J; 1981 May; 74(5):612-5. PubMed ID: 7244722
[TBL] [Abstract][Full Text] [Related]
4. Failure of vancomycin treatment in Staphylococcus aureus endocarditis. In vivo and in vitro observations.
Gopal V; Bisno AL; Silverblatt FJ
JAMA; 1976 Oct; 236(14):1604-6. PubMed ID: 989135
[TBL] [Abstract][Full Text] [Related]
5. Ciprofloxacin versus vancomycin in the therapy of experimental methicillin-resistant Staphylococcus aureus endocarditis.
Kaatz GW; Barriere SL; Schaberg DR; Fekety R
Antimicrob Agents Chemother; 1987 Apr; 31(4):527-30. PubMed ID: 3649202
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Sakoulas G; Eliopoulos GM; Alder J; Eliopoulos CT
Antimicrob Agents Chemother; 2003 May; 47(5):1714-8. PubMed ID: 12709345
[TBL] [Abstract][Full Text] [Related]
7. Oral temafloxacin versus vancomycin for therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
Hessen MT; Pitsakis PG; Kaye D
Antimicrob Agents Chemother; 1990 Jun; 34(6):1143-5. PubMed ID: 2393273
[TBL] [Abstract][Full Text] [Related]
8. Methicillin-resistant Staphylococcus aureus.
Morris JG; Tenney JH
Ann Intern Med; 1983 Aug; 99(2):283-4. PubMed ID: 6881798
[No Abstract] [Full Text] [Related]
9. Ampicillin, sulbactam, and rifampin combination treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits.
Chambers HF; Kartalija M; Sande M
J Infect Dis; 1995 Apr; 171(4):897-902. PubMed ID: 7706817
[TBL] [Abstract][Full Text] [Related]
10. Daptomycin and rifampin for the treatment of methicillin-resistant Staphylococcus aureus septic pulmonary emboli in the absence of endocarditis.
Gomez EO; Jafary A; Dever LL
Microb Drug Resist; 2010 Sep; 16(3):241-4. PubMed ID: 20617926
[TBL] [Abstract][Full Text] [Related]
11. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus.
Fernandez-Guerrero M; Rouse M; Henry N; Wilson W
Antimicrob Agents Chemother; 1988 May; 32(5):747-51. PubMed ID: 3164989
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus bacteremia with the addition of rifampin to daptomycin.
Ahmad NM; Rojtman AD
Ann Pharmacother; 2010 May; 44(5):918-21. PubMed ID: 20354160
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats.
Cantoni L; Wenger A; Glauser MP; Bille J
J Infect Dis; 1989 May; 159(5):989-93. PubMed ID: 2708846
[No Abstract] [Full Text] [Related]
14. Bacteriological efficacy of nafcillin and vancomycin alone or combined with rifampicin or amikacin in experimental meningitis due to methicillin-susceptible or -resistant Staphylococcus aureus.
Sato K; Lin TY; Weintrub L; Olsen K; McCracken GH
Jpn J Antibiot; 1985 Aug; 38(8):2155-62. PubMed ID: 3852897
[TBL] [Abstract][Full Text] [Related]
15. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus epidermidis.
Rouse MS; Wilcox RM; Henry NK; Steckelberg JM; Wilson WR
Antimicrob Agents Chemother; 1990 Feb; 34(2):273-6. PubMed ID: 2327776
[TBL] [Abstract][Full Text] [Related]
16. Addition of rifampin to vancomycin for methicillin-resistant Staphylococcus aureus infections: what is the evidence?
Tremblay S; Lau TT; Ensom MH
Ann Pharmacother; 2013; 47(7-8):1045-54. PubMed ID: 23715070
[TBL] [Abstract][Full Text] [Related]
17. Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis.
Levine DP; Fromm BS; Reddy BR
Ann Intern Med; 1991 Nov; 115(9):674-80. PubMed ID: 1929035
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin or vancomycin plus netilmicin for methicillin- and gentamicin-resistant Staphylococcus aureus aortic valve experimental endocarditis.
Perdikaris G; Giamarellou H; Pefanis A; Donta I; Karayiannakos P
Antimicrob Agents Chemother; 1995 Oct; 39(10):2289-94. PubMed ID: 8619584
[TBL] [Abstract][Full Text] [Related]
19. Rifampin resistance. Development during the therapy of methicillin-resistant Staphylococcus aureus infection.
Eng RH; Smith SM; Tillem M; Cherubin C
Arch Intern Med; 1985 Jan; 145(1):146-8. PubMed ID: 3844314
[TBL] [Abstract][Full Text] [Related]
20. Therapy of methicillin-resistant Staphylococcus epidermidis experimental endocarditis.
Lowy FD; Wexler MA; Steigbigel NH
J Lab Clin Med; 1982 Jul; 100(1):94-104. PubMed ID: 6919570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
